Fabiana Lima Vazquez

Dr. Fabiana Lima Vazquez

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2016 in Acta Cytologica
Verified
Journal Article
Closed access
LMLaura W. Musselwhite
Laura W. Musselwhite
COCristina M. Oliveira
Cristina M. Oliveira
TKTendai Kwaramba
Tendai Kwaramba
NPNaitielle de Paula Pantano
Naitielle de Paula Pantano
JSJennifer S. Smith
Jennifer S. Smith
ALAdhemar Longatto-Filho
Adhemar Longatto-Filho
Invasive cervical cancer disproportionately affects women without sufficient access to care, with higher rates among minority groups in higher-income countries and women in low-resource regions of the world. Many elements contribute to racial/ethnic disparities in the cervical cancer continuum - from screening and diagnosis to treatment and outcome. Sociodemographic factors, access to healthcare, income and education level, and disease stage at diagnosis are closely linked to such inequities. Despite the identification of such elements, racial/ethnic disparities persist, and are widening in several minority subgroups, particularly in older women, who are ineligible for human papillomavirus (HPV) vaccination and are underscreened. Recent studies suggest that racial/ethnic differences in HPV infection exist and may also have a role in observed differences in cervical cancer. In this review, we provide an overview of the current literature on racial disparities in cervical cancer screening, incidence, treatment and outcome to inform future strategies to reduce persistent inequities.

20 January 2015 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
FVFabiana Lima Vazquez
Fabiana Lima Vazquez
KCKarine Laura Cortellazzi
Karine Laura Cortellazzi
AKArmando Koichiro Kaieda
Armando Koichiro Kaieda
JBJaqueline Vilela Bulgareli
Jaqueline Vilela Bulgareli
FMFabio Luiz Mialhe
Fabio Luiz Mialhe
APAntonio Carlos Pereira
Antonio Carlos Pereira
Investigate the individual and contextual variables related to caries in underprivileged adolescents, and the disparity in distribution of the disease.

2 February 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
RCRicardo Filipe Alves Costa
Ricardo Filipe Alves Costa
ALAdhemar Longatto-Filho
Adhemar Longatto-Filho
FVFabiana Lima Vazquez
Fabiana Lima Vazquez
CPCéline Pinheiro
Céline Pinheiro
LZLuiz Carlos Zeferino
Luiz Carlos Zeferino
JFJosé Humberto T.G. Tavares Guerreiro Fregnani
José Humberto T.G. Tavares Guerreiro Fregnani
Quality indicators for the Brazilian cervical cancer screening programme can provide a perspective on its effectiveness in Brazilian macro-regions and states. The aim of this study was to perform a trend analysis of the cervical cancer screening program’s quality indicators, according to Brazilian regions and states, from 2006 to 2013. Using information from approximately 62,000,000 exams obtained from the Information System of Cervical Cancer Screening (SISCOLO), joinpoint analysis was used to calculate the Annual Percentage Change (APC). The estimated number of women in the target age group (25–64 years) who underwent Pap testing over a three-year interval was lower than that recommended by international guidelines in the North, Northeast and Midwest regions, and the trends for this indicator remained stationary over the years in all regions of Brazil. Overall, the index of positivity in Brazilian regions and states is below that preconized by the Brazilian National Cancer Institute (INCA). Additionally, the frequencies of unsatisfactory cases are in line with international guidelines but above those preconized by INCA guidelines. All positive cytological diagnoses were lower than those preconized by INCA. The results show that the cervical cancer screening programme is still far from efficient because most of the quality indicators in Brazilian regions and states are outside of the parameters preconized by national and international organizations.

28 February 2019 in Acta Cytologica
Verified
Journal Article
Closed access
PDF file
JPJúlio Cesar Possati-Resende
Júlio Cesar Possati-Resende
FVFabiana Lima Vazquez
Fabiana Lima Vazquez
NPNaitielle de Paula Pantano
Naitielle de Paula Pantano
JFJosé Humberto T.G. Tavares Guerreiro Fregnani
José Humberto T.G. Tavares Guerreiro Fregnani
EMEdmundo Carvalho Mauad
Edmundo Carvalho Mauad
ALAdhemar Longatto-Filho
Adhemar Longatto-Filho
Background: The implementation of population screening for cervical lesions in rural areas has been particularly challenging for a variety of reasons, including geographic isolation, limited access to medical care, lack of awareness of cancer risks, lower education levels, and embarrassment about having the clinical examination. Methods: This study was designed to evaluate the use of self-sampling for human papillomavirus (HPV) screening in the rural communities served by our hospital. To develop the study group, we trained a local police officer who was already interacting with the rural community to explain cancer risks and the ease of self-sampling to the women. Results: We identified a study group of 386 women, of whom 369 (95.6%) agreed to participate in the study. To test for high-risk HPV, we performed the Cobas PCR test, and of 340 valid samples, 45 (12.2%) were positive for at least 1 of the high-risk HPV subtypes. All positively tested women were referred for colposcopy and Papanicolaou testing. The follow-up biopsies showed that 40% had low-grade intraepithelial neoplasia (CIN1), 6.6% had high-grade intraepithelial neoplasia (CIN2/3), and 4.4% had squamous cell carcinoma. Conclusions: Self-collection for HPV testing by women living in isolated communities is highly efficient and has potential for cost-effective screening by taking advantage of existing support networks, such as the local police service.

19 October 2013 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
CLCristina Martins Lisboa
Cristina Martins Lisboa
JPJanice Simpson De Paula
Janice Simpson De Paula
GAGlaucia Maria Bovi Ambrosano
Glaucia Maria Bovi Ambrosano
APAntonio Carlos Pereira
Antonio Carlos Pereira
MMMarcelo de Castro Meneghim
Marcelo de Castro Meneghim
FMFábio Luiz Mialhe
Fábio Luiz Mialhe
Background: The objective of this study was to compare the socioeconomic and family characteristics of underprivileged schoolchildren with and without curative dental needs participating in a dental health program.Methods: A random sample of 1411 of 8-to-10 year-old Brazilian schoolchildren was examined and two sample groups were included in the cross-sectional study: 544 presented curative dental needs and the other 867 schoolchildren were without curative dental needs. The schoolchildren were examined for the presence of caries lesions using the DMFT index and their parents were asked to answer questions about socioenvironmental characteristics of their families. Logistic regression models were adjusted estimating the Odds Ratios (OR), their 95% confidence intervals (CI), and significance levels.Results: After adjusting for potential confounders, it was found that families earning more than one Brazilian minimum wage, having fewer than four residents in the house, families living in homes owned by them, and children living with both biological parents were protective factors for the presence of dental caries, and consequently, curative dental needs.Conclusions: Socioeconomic status and family structure influences the curative dental needs of children from underprivileged communities. In this sense, dental health programs should plan and implement strategic efforts to reduce inequities in oral health status and access to oral health services of vulnerable schoolchildren and their families.

5 May 2020 in Pathobiology
Verified
Journal Article
Open access
NCNathália C. Campanella
Nathália C. Campanella
ESEduardo Caetano Silva
Eduardo Caetano Silva
GDGustavo Dix
Gustavo Dix
FVFabiana Lima Vazquez
Fabiana Lima Vazquez
FPFlávia Escremim de Paula
Flávia Escremim de Paula
RRRui M. Reis
Rui M. Reis
Background: Malignant pleural mesothelioma (MPM) is a highly lethal disease comprising a heterogeneous group of tumors with challenging to predict biological behavior. The diagnosis is complex, and the histologic classification includes 2 major subtypes of MPM: epithelioid (∼60% of cases) and sarcomatous (∼20%). Its identification depends upon pathological investigation supported by clinical and radiological evidence and more recently ancillary molecular testing. Treatment options are currently limited, with no known targeted therapies available. Objectives: To elucidate the mutation profile of driver tumor suppressor and oncogenic genes in a cohort of Brazilian patients. Methods: We sequenced 16 driver genes in a series of 43 Brazilian malignant mesothelioma (MM) patients from 3 distinct Brazilian centers. Genomic DNA was extracted from formalin-fixed paraffin-embedded tumor tissue blocks, and the TERT promoter region was amplified by PCR followed by direct capillary sequencing. The Illumina TruSight Tumor 15 was used to evaluate 250 amplicons from 15 genes associated with solid tumors (AKT1, GNA11, NRAS, BRAF, GNAQ, PDGFRA, EGFR, KIT, PIK3CA, ERBB2, KRAS, RET, FOXL2, MET,and TP53). Library preparation with the TruSight Tumor 15 was performed before sequencing at the MiSeq platform. Data analysis was performed using Sophia DDM software. Results: Out of 43 MPM patients, 38 (88.4%) were epithelioid subtype and 5 (11.6%) were sarcomatoid histotype. Asbestos exposure was present in 15 (39.5%) patients with epithelioid MPM and 3 (60%) patients with sarcomatoid MPM. We found a TERT promoter mutation in 11.6% of MM, and the c.-146C>T mutation was the most common event. The next-generation sequencing was successful in 33 cases. A total of 18 samples showed at least 1 pathogenic, with a median of 1.8 variants, ranging from 1 to 6. The most mutated genes were TP53 and ERBB2 with 7 variants each, followed by NRAS BRAF, PI3KCA, EGFR and PDGFRA with 2 variants each. KIT, AKT1, and FOXL2 genes exhibited 1 variant each. Interestingly, 2 variants observed in the PDGFRA gene are classic imatinib-sensitive therapy. Conclusions: We concluded that Brazilian MPM harbor mutation in classic tumor suppressor and oncogenic genes, which might help in the guidance of personalized treatment of MPM.